EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives

Jiaqi Zhou, Chengwang Guo iD, Mingze Zhang, Xi Guo, Jihong Wang, Xiaojun Liu, Peng Nie, Yuntao Ma

Cancer Medicine · 2026-03 · 15 (3)

DOI: 10.1002/cam4.71753 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 24.03.2026. Verfasst von Jiaqi Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical School of Gansu University of Chinese Medicine, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Stomach Neoplasms, Adenocarcinoma, Esophagogastric Junction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Gansu Province, Wu Jieping Medical Foundation Scientific Research Grant, Wuwei Clinical Research Center for Gastric.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with locally advanced gastric/gastroesophageal junction adenocarcinoma posing significant therapeutic challenges. Neoadjuvant therapy has emerged as a critical strategy to improve surgical outcomes and long‐term survival by reducing tumor burden and eradicating micrometastases. This systematic review integrates evidence from more than 100 clinical trials and 20 meta‐analyses published in recent years. It focuses on new advances in neoadjuvant therapies for gastric cancer, including chemotherapy, radiotherapy, immunotherapy, and targeted therapies, while highlighting emerging combination strategies and unresolved clinical dilemmas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyStomach NeoplasmsAdenocarcinomaEsophagogastric JunctionEsophageal NeoplasmsHumansImmunotherapy

Stichwörter der Autor:innen

chemotherapygastric cancerimmunotherapyneoadjuvant therapytargeted therapy

Autor:innen und Institutionen

  • The First Clinical School of Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
  • Department of General Surgery, Mianyang 404 Hospital, Mianyang, China.
  • Department of Gastric Tumor Surgery, Gansu Wuwei Tumor Hospital, Wuwei, Gansu, China.

ORCID-Profile: Chengwang Guo

Förderung

  • Science and Technology Department of Gansu Province
  • Wu Jieping Medical Foundation Scientific Research Grant
  • Wuwei Clinical Research Center for Gastric

Zitieren

APA

Zhou, J., Guo, C., Zhang, M., Guo, X., Wang, J., Liu, X., Nie, P., & Ma, Y. (2026). Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71753

Vancouver

Zhou J, Guo C, Zhang M, Guo X, Wang J, Liu X, et al. Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71753

BibTeX
@article{Zhou2026,
  author = {Zhou, Jiaqi and Guo, Chengwang and Zhang, Mingze and Guo, Xi and Wang, Jihong and Liu, Xiaojun and Nie, Peng and Ma, Yuntao},
  title = {Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1002/cam4.71753}
}
Kostenlos starten →